Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...
Dr. Sara Brenner, who has been FDA CDRH's in vitro diagnostics chief medical officer, is serving as acting commissioner of ...
The FDA has tapped Sara Brenner to serve as acting commissioner as it awaits new leadership from the Trump administration to ...
Brenner, who worked in the FDA’s Center for Devices and Radiological Health, will take the helm of the agency until a new ...
Brenner, who has worked in the FDA’s Center for Devices and Radiological Health, will lead the agency until a permanent ...
The Trump administration tapped Sara Brenner, a career FDA official, to serve as the acting commissioner of the agency.
Dr. Sara Brenner has been named acting commissioner of the Food and Drug Administration. Brenner replaces Dr. Robert Califf. The announcement was made ...
Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a novel treatment to treat autism spectrum ...
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...
New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...
Retailers now have less than one year to meet the requirements of section 204 of the Food Safety Modernization Act (FSMA), ...
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback